Clinical Trials Browser

Phase 1/2 × Terminated × Hypoxia × Clear all

NCT05119335 2025-11-12

A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Phase 1/2 Terminated

Hypoxia, Carcinoma, Renal Cell, Kidney Neoplasms